nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—SLC47A1—Metformin—polycystic ovary syndrome	0.691	1	CbGbCtD
Ondansetron—HTR4—adrenal cortex—polycystic ovary syndrome	0.00854	0.103	CbGeAlD
Ondansetron—HTR4—pituitary gland—polycystic ovary syndrome	0.0069	0.0834	CbGeAlD
Ondansetron—HTR4—adrenal gland—polycystic ovary syndrome	0.00616	0.0745	CbGeAlD
Ondansetron—CYP1A2—urine—polycystic ovary syndrome	0.00449	0.0543	CbGeAlD
Ondansetron—SLC47A2—vagina—polycystic ovary syndrome	0.00433	0.0523	CbGeAlD
Ondansetron—CYP2C9—urine—polycystic ovary syndrome	0.00426	0.0515	CbGeAlD
Ondansetron—CYP2E1—urine—polycystic ovary syndrome	0.00404	0.0488	CbGeAlD
Ondansetron—CYP3A4—urine—polycystic ovary syndrome	0.00325	0.0393	CbGeAlD
Ondansetron—CYP2D6—urine—polycystic ovary syndrome	0.0032	0.0387	CbGeAlD
Ondansetron—SLC47A1—adrenal cortex—polycystic ovary syndrome	0.00226	0.0274	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00204	0.0247	CbGeAlD
Ondansetron—SLC47A1—endometrium—polycystic ovary syndrome	0.00202	0.0244	CbGeAlD
Ondansetron—SLC47A1—uterus—polycystic ovary syndrome	0.00186	0.0225	CbGeAlD
Ondansetron—SLC47A1—pituitary gland—polycystic ovary syndrome	0.00183	0.0221	CbGeAlD
Ondansetron—SLC47A1—adipose tissue—polycystic ovary syndrome	0.00182	0.022	CbGeAlD
Ondansetron—SLC47A1—adrenal gland—polycystic ovary syndrome	0.00163	0.0198	CbGeAlD
Ondansetron—SLC47A1—female gonad—polycystic ovary syndrome	0.00152	0.0184	CbGeAlD
Ondansetron—SLC47A1—vagina—polycystic ovary syndrome	0.00152	0.0183	CbGeAlD
Ondansetron—SLC47A1—endocrine gland—polycystic ovary syndrome	0.00142	0.0171	CbGeAlD
Ondansetron—OPRM1—endocrine gland—polycystic ovary syndrome	0.00132	0.016	CbGeAlD
Ondansetron—KCNH2—endometrium—polycystic ovary syndrome	0.00124	0.015	CbGeAlD
Ondansetron—HTR1B—endocrine gland—polycystic ovary syndrome	0.00121	0.0146	CbGeAlD
Ondansetron—KCNH2—uterus—polycystic ovary syndrome	0.00114	0.0138	CbGeAlD
Ondansetron—HTR1A—adrenal gland—polycystic ovary syndrome	0.00113	0.0136	CbGeAlD
Ondansetron—KCNH2—pituitary gland—polycystic ovary syndrome	0.00112	0.0136	CbGeAlD
Ondansetron—KCNH2—adrenal gland—polycystic ovary syndrome	0.001	0.0121	CbGeAlD
Ondansetron—HTR1A—endocrine gland—polycystic ovary syndrome	0.000977	0.0118	CbGeAlD
Ondansetron—KCNH2—female gonad—polycystic ovary syndrome	0.000935	0.0113	CbGeAlD
Ondansetron—KCNH2—vagina—polycystic ovary syndrome	0.00093	0.0112	CbGeAlD
Ondansetron—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000923	0.0112	CbGeAlD
Ondansetron—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000876	0.0391	CcSEcCtD
Ondansetron—KCNH2—endocrine gland—polycystic ovary syndrome	0.00087	0.0105	CbGeAlD
Ondansetron—Angina pectoris—Metformin—polycystic ovary syndrome	0.000799	0.0356	CcSEcCtD
Ondansetron—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000772	0.00934	CbGeAlD
Ondansetron—CYP3A5—female gonad—polycystic ovary syndrome	0.000772	0.00934	CbGeAlD
Ondansetron—CYP3A5—vagina—polycystic ovary syndrome	0.000768	0.00928	CbGeAlD
Ondansetron—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000745	0.009	CbGeAlD
Ondansetron—Drowsiness—Metformin—polycystic ovary syndrome	0.000731	0.0326	CcSEcCtD
Ondansetron—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000718	0.00868	CbGeAlD
Ondansetron—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000707	0.00855	CbGeAlD
Ondansetron—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000691	0.0308	CcSEcCtD
Ondansetron—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00067	0.0081	CbGeAlD
Ondansetron—Bradycardia—Metformin—polycystic ovary syndrome	0.000668	0.0298	CcSEcCtD
Ondansetron—Eye disorder—Metformin—polycystic ovary syndrome	0.000613	0.0274	CcSEcCtD
Ondansetron—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000609	0.0272	CcSEcCtD
Ondansetron—Flushing—Metformin—polycystic ovary syndrome	0.000609	0.0272	CcSEcCtD
Ondansetron—Angiopathy—Metformin—polycystic ovary syndrome	0.000595	0.0266	CcSEcCtD
Ondansetron—Immune system disorder—Metformin—polycystic ovary syndrome	0.000593	0.0264	CcSEcCtD
Ondansetron—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000591	0.0264	CcSEcCtD
Ondansetron—Chills—Metformin—polycystic ovary syndrome	0.000589	0.0263	CcSEcCtD
Ondansetron—Erythema—Metformin—polycystic ovary syndrome	0.000571	0.0255	CcSEcCtD
Ondansetron—CYP2D6—female gonad—polycystic ovary syndrome	0.00057	0.0069	CbGeAlD
Ondansetron—Flatulence—Metformin—polycystic ovary syndrome	0.000563	0.0251	CcSEcCtD
Ondansetron—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000539	0.00652	CbGeAlD
Ondansetron—Vision blurred—Metformin—polycystic ovary syndrome	0.000538	0.024	CcSEcCtD
Ondansetron—Tremor—Metformin—polycystic ovary syndrome	0.000535	0.0239	CcSEcCtD
Ondansetron—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00053	0.00641	CbGeAlD
Ondansetron—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00053	0.0236	CcSEcCtD
Ondansetron—Malaise—Metformin—polycystic ovary syndrome	0.000515	0.023	CcSEcCtD
Ondansetron—Syncope—Metformin—polycystic ovary syndrome	0.000512	0.0229	CcSEcCtD
Ondansetron—Palpitations—Metformin—polycystic ovary syndrome	0.000505	0.0225	CcSEcCtD
Ondansetron—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000502	0.0224	CcSEcCtD
Ondansetron—Chest pain—Metformin—polycystic ovary syndrome	0.000486	0.0217	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000483	0.0215	CcSEcCtD
Ondansetron—Discomfort—Metformin—polycystic ovary syndrome	0.000481	0.0214	CcSEcCtD
Ondansetron—Shock—Metformin—polycystic ovary syndrome	0.000459	0.0205	CcSEcCtD
Ondansetron—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000457	0.0204	CcSEcCtD
Ondansetron—Skin disorder—Metformin—polycystic ovary syndrome	0.000453	0.0202	CcSEcCtD
Ondansetron—Hypotension—Metformin—polycystic ovary syndrome	0.000436	0.0194	CcSEcCtD
Ondansetron—Paraesthesia—Metformin—polycystic ovary syndrome	0.000419	0.0187	CcSEcCtD
Ondansetron—Dyspnoea—Metformin—polycystic ovary syndrome	0.000416	0.0185	CcSEcCtD
Ondansetron—Somnolence—Metformin—polycystic ovary syndrome	0.000414	0.0185	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000403	0.018	CcSEcCtD
Ondansetron—Fatigue—Metformin—polycystic ovary syndrome	0.000402	0.0179	CcSEcCtD
Ondansetron—Constipation—Metformin—polycystic ovary syndrome	0.000399	0.0178	CcSEcCtD
Ondansetron—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000384	0.0171	CcSEcCtD
Ondansetron—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000381	0.017	CcSEcCtD
Ondansetron—Urticaria—Metformin—polycystic ovary syndrome	0.00037	0.0165	CcSEcCtD
Ondansetron—Abdominal pain—Metformin—polycystic ovary syndrome	0.000369	0.0164	CcSEcCtD
Ondansetron—Asthenia—Metformin—polycystic ovary syndrome	0.000335	0.0149	CcSEcCtD
Ondansetron—Pruritus—Metformin—polycystic ovary syndrome	0.00033	0.0147	CcSEcCtD
Ondansetron—Diarrhoea—Metformin—polycystic ovary syndrome	0.000319	0.0142	CcSEcCtD
Ondansetron—Dizziness—Metformin—polycystic ovary syndrome	0.000308	0.0138	CcSEcCtD
Ondansetron—Vomiting—Metformin—polycystic ovary syndrome	0.000296	0.0132	CcSEcCtD
Ondansetron—Rash—Metformin—polycystic ovary syndrome	0.000294	0.0131	CcSEcCtD
Ondansetron—Dermatitis—Metformin—polycystic ovary syndrome	0.000294	0.0131	CcSEcCtD
Ondansetron—Headache—Metformin—polycystic ovary syndrome	0.000292	0.013	CcSEcCtD
Ondansetron—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.74e-05	0.000134	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.72e-05	0.000133	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	2.72e-05	0.000133	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.7e-05	0.000132	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.68e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	2.68e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.67e-05	0.000131	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.66e-05	0.00013	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.65e-05	0.00013	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.64e-05	0.000129	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.63e-05	0.000129	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.63e-05	0.000129	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	2.61e-05	0.000128	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.61e-05	0.000128	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	2.6e-05	0.000127	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.59e-05	0.000127	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.58e-05	0.000126	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.56e-05	0.000125	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.55e-05	0.000125	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.55e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.55e-05	0.000125	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.54e-05	0.000124	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.51e-05	0.000123	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—polycystic ovary syndrome	2.5e-05	0.000123	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.49e-05	0.000122	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.46e-05	0.00012	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.44e-05	0.000119	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.43e-05	0.000119	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.43e-05	0.000119	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	2.42e-05	0.000119	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	2.41e-05	0.000118	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	2.4e-05	0.000118	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	2.39e-05	0.000117	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	2.38e-05	0.000117	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.35e-05	0.000115	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—TH—polycystic ovary syndrome	2.35e-05	0.000115	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.34e-05	0.000115	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.32e-05	0.000113	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.31e-05	0.000113	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.31e-05	0.000113	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	2.31e-05	0.000113	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	2.31e-05	0.000113	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	2.29e-05	0.000112	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.28e-05	0.000112	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.28e-05	0.000112	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.26e-05	0.000111	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.26e-05	0.00011	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.25e-05	0.00011	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.24e-05	0.000109	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	2.23e-05	0.000109	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.23e-05	0.000109	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	2.23e-05	0.000109	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.22e-05	0.000109	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.16e-05	0.000106	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.16e-05	0.000106	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	2.15e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	2.14e-05	0.000105	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.14e-05	0.000105	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.14e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	2.14e-05	0.000105	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.13e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.13e-05	0.000104	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.13e-05	0.000104	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	2.12e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	2.12e-05	0.000104	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.12e-05	0.000104	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	2.11e-05	0.000103	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	2.11e-05	0.000103	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.1e-05	0.000103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.1e-05	0.000103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.1e-05	0.000103	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.09e-05	0.000102	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.04e-05	0.0001	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.02e-05	9.89e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.01e-05	9.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.01e-05	9.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2e-05	9.79e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	2e-05	9.78e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.99e-05	9.76e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.98e-05	9.7e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.98e-05	9.67e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.97e-05	9.63e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.96e-05	9.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.95e-05	9.55e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.95e-05	9.52e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.94e-05	9.5e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.93e-05	9.44e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	1.92e-05	9.39e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.9e-05	9.31e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.89e-05	9.27e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.89e-05	9.23e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.86e-05	9.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.85e-05	9.04e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.84e-05	9.01e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.83e-05	8.98e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.83e-05	8.96e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	1.83e-05	8.94e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.83e-05	8.94e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.81e-05	8.88e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.81e-05	8.85e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.79e-05	8.74e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.78e-05	8.69e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.76e-05	8.63e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.74e-05	8.53e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.74e-05	8.5e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.73e-05	8.48e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.72e-05	8.42e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TH—polycystic ovary syndrome	1.7e-05	8.33e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.7e-05	8.31e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.69e-05	8.3e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.69e-05	8.29e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.69e-05	8.28e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.68e-05	8.22e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.66e-05	8.11e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	1.66e-05	8.1e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.65e-05	8.09e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.65e-05	8.07e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.64e-05	8.03e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.64e-05	8.03e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.63e-05	7.96e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.61e-05	7.9e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.61e-05	7.88e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.61e-05	7.88e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.58e-05	7.74e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.57e-05	7.68e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.56e-05	7.64e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	1.56e-05	7.62e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.55e-05	7.6e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.53e-05	7.5e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.52e-05	7.44e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.51e-05	7.38e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.51e-05	7.37e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.5e-05	7.35e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.5e-05	7.33e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.49e-05	7.31e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.49e-05	7.28e-05	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—polycystic ovary syndrome	1.48e-05	7.24e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.48e-05	7.23e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.48e-05	7.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.46e-05	7.16e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	1.46e-05	7.15e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.44e-05	7.03e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	1.42e-05	6.96e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.42e-05	6.94e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	1.41e-05	6.92e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.41e-05	6.88e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.4e-05	6.83e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.39e-05	6.83e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.39e-05	6.81e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	1.39e-05	6.8e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.39e-05	6.79e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.38e-05	6.77e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.37e-05	6.7e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.37e-05	6.69e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.34e-05	6.56e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	1.32e-05	6.48e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.32e-05	6.46e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.31e-05	6.41e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.3e-05	6.38e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.3e-05	6.36e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.29e-05	6.32e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.29e-05	6.31e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.29e-05	6.3e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.28e-05	6.29e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.28e-05	6.27e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.27e-05	6.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.27e-05	6.22e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.26e-05	6.18e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.26e-05	6.17e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	1.26e-05	6.15e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	1.25e-05	6.14e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.25e-05	6.13e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	1.25e-05	6.11e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.24e-05	6.08e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.21e-05	5.91e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.21e-05	5.91e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.21e-05	5.91e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.2e-05	5.89e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.2e-05	5.88e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.2e-05	5.86e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.18e-05	5.79e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.17e-05	5.75e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	1.17e-05	5.72e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.17e-05	5.71e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.16e-05	5.7e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.15e-05	5.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.13e-05	5.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.11e-05	5.42e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.1e-05	5.41e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.1e-05	5.36e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.08e-05	5.3e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	1.08e-05	5.27e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.07e-05	5.25e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	1.05e-05	5.12e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.04e-05	5.1e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.04e-05	5.1e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.03e-05	5.06e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.02e-05	5.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	9.95e-06	4.87e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.94e-06	4.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.9e-06	4.85e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	9.86e-06	4.83e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	9.82e-06	4.8e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	9.77e-06	4.78e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	9.49e-06	4.64e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	9.47e-06	4.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.39e-06	4.6e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.36e-06	4.58e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	9.35e-06	4.58e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	9.34e-06	4.57e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.31e-06	4.56e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—INS—polycystic ovary syndrome	9.3e-06	4.55e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—INS—polycystic ovary syndrome	9.28e-06	4.54e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.27e-06	4.54e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.24e-06	4.52e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.13e-06	4.47e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.94e-06	4.37e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.9e-06	4.36e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.83e-06	4.32e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.35e-06	4.09e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.3e-06	4.06e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.23e-06	4.03e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.97e-06	3.9e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	7.96e-06	3.89e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.9e-06	3.86e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.89e-06	3.86e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.68e-06	3.76e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.54e-06	3.69e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.22e-06	3.53e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.03e-06	3.44e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.81e-06	3.33e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.73e-06	3.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.67e-06	3.27e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.64e-06	3.25e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.6e-06	3.23e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.58e-06	3.22e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.54e-06	3.2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.45e-06	3.15e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	6.18e-06	3.03e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.14e-06	3.01e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.82e-06	2.85e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.7e-06	2.79e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.62e-06	2.75e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.59e-06	2.74e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	5.46e-06	2.67e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.43e-06	2.66e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.71e-06	2.3e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.4e-06	2.15e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.34e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.32e-06	2.11e-05	CbGpPWpGaD
